For the quarter ending 2026-03-31, UTHR made $781,500K in revenue. $274,900K in net income. Net profit margin of 35.18%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 781,500 | 790,200 | 799,500 | 798,600 |
| Cost of sales | 133,400 | 103,400 | 100,900 | 87,600 |
| Research and development | 138,200 | 139,500 | 127,500 | 134,000 |
| Selling, general, and administrative | 184,100 | 190,600 | 182,600 | 212,500 |
| Total operating expenses | 455,700 | 433,500 | 411,000 | 434,100 |
| Operating income | 325,800 | 356,700 | 388,500 | 364,500 |
| Interest income | 41,800 | 43,200 | 46,400 | 51,300 |
| Interest expense | 3,000 | 3,100 | 3,000 | 7,300 |
| Other expense, net | -46,300 | 47,200 | 6,100 | -100 |
| Total other (expense) income, net | -7,500 | 87,300 | 49,500 | 43,900 |
| Income before income taxes | 318,300 | 444,000 | 438,000 | 408,400 |
| Income tax expense | 43,400 | 79,700 | 99,300 | 98,900 |
| Net income | 274,900 | 364,300 | 338,700 | 309,500 |
| Basic EPS | 6.32 | 8.394 | 7.73 | 6.86 |
| Diluted EPS | 5.82 | 7.686 | 7.16 | 6.41 |
| Basic Average Shares | 43,500,000 | 43,400,000 | 43,800,000 | 45,100,000 |
| Diluted Average Shares | 47,200,000 | 47,400,000 | 47,300,000 | 48,300,000 |
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)